SCHIZOPHRENIA BULLETIN

Scope & Guideline

Exploring the complexities of mental health.

Introduction

Delve into the academic richness of SCHIZOPHRENIA BULLETIN with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN0586-7614
PublisherOXFORD UNIV PRESS
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1973 to 2024
AbbreviationSCHIZOPHRENIA BULL / Schizophr. Bull.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressGREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND

Aims and Scopes

The 'Schizophrenia Bulletin' focuses on advancing the understanding of schizophrenia and related disorders through a multidisciplinary approach. The journal aims to disseminate high-quality research that spans various aspects of schizophrenia, including neurobiological, psychological, and social dimensions.
  1. Neurobiological Mechanisms:
    Research exploring the underlying neurobiological mechanisms of schizophrenia, including genetics, neuroimaging, and molecular biology, to better understand the pathophysiology of the disorder.
  2. Psychological and Cognitive Aspects:
    Studies examining cognitive deficits, emotional regulation, and psychosocial factors that contribute to the experience of schizophrenia, emphasizing the interplay between mental processes and symptoms.
  3. Treatment and Intervention Strategies:
    Investigations into pharmacological and non-pharmacological interventions, including cognitive remediation, psychosocial therapies, and innovative treatment approaches such as digital health interventions.
  4. Epidemiological and Public Health Perspectives:
    Research addressing epidemiology, risk factors, and health disparities related to schizophrenia, focusing on societal impacts and the effectiveness of public health strategies.
  5. Transdiagnostic Approaches:
    Explorations of concepts that span various psychiatric disorders, including the study of psychosis risk and shared mechanisms with other mental health conditions.
The 'Schizophrenia Bulletin' has shown a dynamic shift in focus towards emerging themes that resonate with current clinical and societal needs in the field of schizophrenia research.
  1. Digital Health Interventions:
    A growing number of studies explore the efficacy of digital health technologies, such as teletherapy and mobile health applications, highlighting their potential to improve access to care and patient outcomes.
  2. Transdiagnostic Research:
    An increase in research that examines psychosis across various diagnostic categories, emphasizing shared mechanisms and risk factors, reflecting a move towards understanding mental health in a more integrated manner.
  3. Cognitive Remediation and Functionality:
    There is a notable rise in studies investigating cognitive remediation strategies aimed at improving functional outcomes in individuals with schizophrenia, indicating a shift towards enhancing quality of life.
  4. Social and Environmental Factors:
    Emerging research emphasizes the role of social determinants, such as socioeconomic status and childhood adversity, in the onset and progression of schizophrenia, underscoring the need for a holistic understanding of the disorder.
  5. Machine Learning and AI in Psychiatry:
    The application of machine learning and artificial intelligence to predict treatment responses, identify biomarkers, and enhance diagnostic accuracy is on the rise, indicating a trend towards incorporating advanced technology in psychiatric research.

Declining or Waning

While the journal continues to cover a broad range of topics, certain areas of research appear to be declining in prominence based on recent publications.
  1. Historical Perspectives on Antipsychotic Medications:
    Although historical analyses of antipsychotic medications have been foundational, recent publications indicate a shift towards contemporary research focusing on innovative interventions and current treatment paradigms.
  2. Single-Disease Focus:
    There seems to be a waning emphasis on studies that exclusively examine schizophrenia without considering comorbid conditions or broader psychiatric contexts, reflecting a trend towards more integrated approaches.
  3. Basic Science Studies:
    The volume of purely basic science studies, such as animal models without translational implications, appears to be decreasing, as the journal increasingly prioritizes research with direct clinical relevance.

Similar Journals

Klinik Psikiyatri Dergisi-Turkish Journal of Clinical Psychiatry

Advancing Mental Health Knowledge for All
Publisher: KLINIK PSIKIYATRI DERGISIISSN: 1302-0099Frequency: 4 issues/year

Klinik Psikiyatri Dergisi - Turkish Journal of Clinical Psychiatry is a distinguished open-access journal dedicated to the evolving field of psychiatry and mental health. Published by KLINIK PSIKIYATRI DERGISI in Turkey since 1998, this journal aims to provide a platform for the dissemination of research, clinical studies, and reviews that contribute to the understanding of psychological disorders and treatment methodologies. With an ISSN of 1302-0099 and an E-ISSN of 2146-7153, the journal is indexed in various databases, although it currently holds a rank of 460/567 in the Scopus ranking for the category of Medicine: Psychiatry and Mental Health. The journal operates under an open-access model, ensuring that research findings are readily accessible to a wide audience, contributing to greater knowledge and awareness in the field. As it converges from 2017 to 2024, Klinik Psikiyatri Dergisi continues to strive for excellence, providing valuable insights and resources for researchers, professionals, and students interested in the complexities of mental health.

Translational Psychiatry

Championing open access to groundbreaking psychiatric research.
Publisher: SPRINGERNATUREISSN: 2158-3188Frequency: 1 issue/year

Translational Psychiatry, an esteemed journal published by SpringerNature, is at the forefront of research in the fields of biological psychiatry, neuroscience, and mental health. With an impressive Q1 category ranking in Biological Psychiatry, Cellular and Molecular Neuroscience, and Psychiatry and Mental Health, the journal fosters high-quality scholarly work that informs clinical practices and guides future research directions. Since its inception in 2011, Translational Psychiatry has embraced the Open Access model, ensuring that groundbreaking findings are easily accessible to all, promoting collaboration and innovation within the global scientific community. With a solid ranking in Scopus—particularly at #33 out of 567 in Psychiatry and Mental Health and #6 out of 51 in Biological Psychiatry—this journal plays a critical role in advancing our understanding of mental health disorders, bridging the gap between bench science and clinical application. As it continues evolving through its converged years from 2011 to 2024, Translational Psychiatry remains an essential resource for researchers, healthcare professionals, and students dedicated to improving mental health outcomes.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Enhancing understanding of psychiatric disorders in older adults.
Publisher: WILEYISSN: 0885-6230Frequency: 12 issues/year

International Journal of Geriatric Psychiatry, published by Wiley, stands as a premier journal dedicated to advancing the field of mental health in older adults. With an impressive impact factor reflective of its Q1 categorization in both Geriatrics and Gerontology, as well as Psychiatry and Mental Health, this journal addresses the critical intersection of aging and mental health, providing a platform for impactful research from 1986 through 2024. Researchers and professionals will find the journal invaluable, as it offers comprehensive insights into a range of subjects pertinent to geriatric mental health, with its ranking in Scopus highlighting its academic rigor and relevance (Rank #147/567 in Psychiatry and Mental Health; Rank #37/116 in Geriatrics and Gerontology). Though it operates on a traditional subscription model, the journal's significant contributions to the understanding of psychiatric disorders in the elderly make it a key resource for anyone involved in geriatric care and research.

BJPsych Open

Advancing mental health scholarship for a brighter tomorrow.
Publisher: CAMBRIDGE UNIV PRESSISSN: 2056-4724Frequency: 6 issues/year

BJPsych Open, published by Cambridge University Press, is a leading open access journal dedicated to the field of psychiatry and mental health. Since its inception in 2015, the journal has provided a platform for disseminating cutting-edge research and evidence-based practices, making significant contributions to the academic community. With an impressive impact factor and currently ranking in the top Q1 quartile of its field, BJPsych Open is recognized for its rigor and relevance, ranking 138 out of 567 journals in psychiatry and mental health according to Scopus, placing it in the 75th percentile. The journal's commitment to open access enhances visibility and accessibility, ensuring that vital research is available to a global audience. Researchers, professionals, and students alike will find valuable insights into contemporary mental health challenges and innovative treatment approaches, making BJPsych Open an essential resource for advancing mental health scholarship.

BMC Psychiatry

Unveiling the future of mental health through rigorous research.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Psychiatry is a leading open-access journal published by BMC, dedicated to advancing the field of psychiatry and mental health. With its E-ISSN 1471-244X, the journal has been at the forefront of disseminating high-quality research since its inception in 2001, and it proudly maintains a Q1 ranking among psychiatry and mental health journals, reflecting its significant impact and relevance within the research community. Based in the United Kingdom, BMC Psychiatry boasts a commendable Scopus ranking of #158 out of 567 in the psychiatry and mental health category, placing it in the 72nd percentile. The journal serves as a vital platform for scholars, clinicians, and students alike, providing them with access to groundbreaking studies, innovative methodologies, and emerging trends in mental health. By fostering a collaborative environment, BMC Psychiatry not only enriches the academic landscape but also contributes to evidence-based practice and policy in mental health care.

Neuropsychopharmacology Reports

Pioneering discoveries in the field of neuropsychopharmacology.
Publisher: WILEYISSN: Frequency: 4 issues/year

Neuropsychopharmacology Reports is a leading open-access journal published by WILEY, dedicated to advancing the fields of clinical psychology, pharmacology, psychiatry, and mental health. Established in 2018, the journal aims to disseminate high-quality research findings, critical reviews, and innovative methodologies that elucidate the complexities of neuropsychopharmacology in enhancing mental health outcomes. With an impressive impact indicated by its Q2 rankings in several categories including Clinical Psychology and Pharmacology (medical) as of 2023, Neuropsychopharmacology Reports stands out as a vital resource for researchers, professionals, and students keen on exploring the interplay between pharmacological interventions and psychological well-being. The journal’s open-access nature ensures that critical advancements in this rapidly evolving field are readily available to a global audience, fostering collaboration and discourse among scholars and practitioners alike. Building on its indexed status with Scopus, the journal is positioned as a noteworthy contributor to ongoing discussions and developments in psychiatry and medical pharmacology.

American Journal of Alzheimers Disease and Other Dementias

Connecting researchers and clinicians for impactful discoveries.
Publisher: SAGE PUBLICATIONS INCISSN: 1533-3175Frequency: 81 issues/year

The American Journal of Alzheimer's Disease and Other Dementias, published by SAGE Publications Inc, is a pivotal resource for researchers, clinicians, and students engaged in the study of neurodegenerative diseases, particularly Alzheimer’s disease and various forms of dementia. With an impact factor reflecting its significance in the field, the journal boasts an open-access format since 2020, ensuring that groundbreaking research is accessible to a global audience. The journal holds prestigious Q2 rankings across several categories, including Clinical Psychology, Geriatrics and Gerontology, Neuroscience, and Psychiatry and Mental Health. Covering a wide spectrum from 1986 to 2024, it provides essential insights into innovative treatments, care strategies, and the latest findings in dementia research, solidifying its importance in fostering knowledge and advancing the field. With a commitment to high-quality scholarship, this journal is an indispensable tool for advancing understanding in the dynamic landscape of dementia studies.

PSYCHIATRY AND CLINICAL NEUROSCIENCES

Innovating Research for Better Mental Health Outcomes
Publisher: WILEYISSN: 1323-1316Frequency: 12 issues/year

PSYCHIATRY AND CLINICAL NEUROSCIENCES is a leading journal in the fields of psychiatry and clinical neurology, published by Wiley. With a commendable impact factor and a position within the prestigious Q1 quartile across multiple relevant categories—including Medicine (Miscellaneous), Neurology, and Psychiatry and Mental Health—this journal stands out for its rigorous peer-reviewed content that addresses critical issues in mental health and neurological disorders. Established in 1933, the journal has a rich history of contributing impactful research that guides both clinical practice and academic inquiry. Although it is not an open-access journal, its high relevance is underscored by its Scopus rankings, with notable percentiles in Psychiatry and Neurology, making it a vital resource for researchers, clinicians, and students looking to stay abreast of the latest advancements. Located in the United Kingdom, PSYCHIATRY AND CLINICAL NEUROSCIENCES aims to bridge the gap between theory and practical application, fostering a comprehensive understanding of the complex interplay between mental health and neurological conditions.

Schizophrenia

Pioneering Discoveries in Schizophrenia Care
Publisher: NATURE PORTFOLIOISSN: Frequency:

Schizophrenia, published by NATURE PORTFOLIO, is a pioneering open-access journal established in 2022, dedicated to advancing the scientific understanding of schizophrenia and its associated disorders. With its commitment to disseminating high-quality research without barriers, this journal aims to provide a platform for innovative studies, reviews, and meta-analyses that enhance clinical practices and therapeutic approaches. The journal is strategically located in Berlin, Germany, a hub for mental health research and innovation. By facilitating open exchange among researchers, professionals, and students, Schizophrenia aspires to be at the forefront of the global discourse on psychiatric disorders, driving forward critical advancements that can translate into improved patient care and outcomes. With a focus on promoting the latest findings in epidemiology, neurobiology, pharmacology, and psychosocial interventions, this journal is poised to become an essential resource for scholars and practitioners alike, eager to make significant contributions to the field.

JOURNAL OF NEPHROLOGY

Fostering critical discussions in nephrological science.
Publisher: SPRINGER HEIDELBERGISSN: 1121-8428Frequency: 9 issues/year

JOURNAL OF NEPHROLOGY is a premier academic journal dedicated to the field of nephrology, published by Springer Heidelberg. With its ISSN 1121-8428 and E-ISSN 1724-6059, this journal serves as a dynamic platform for disseminating high-quality research and groundbreaking findings in kidney health and disease. Since its inception in 1989, it has established itself as a vital resource for professionals, researchers, and students, consistently ranking in the top quartile (Q1) of nephrology journals and securing an impressive Scopus rank of #19 out of 81, placing it in the 77th percentile. Although it operates under a subscription model, the journal fosters an inclusive academic environment where critical discussions and innovative approaches to nephrological challenges are encouraged. With a commitment to advancing knowledge and practice in nephrology, JOURNAL OF NEPHROLOGY remains an essential resource for anyone who seeks to stay at the forefront of kidney research and clinical care.